Advanced search
Publication Cover
Autoimmunity Volume 29, 1999 - Issue 1
Submit an article Journal homepage
41
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Appearance of Islet Cell Autoantibodies after Clinical Diagnosis of Diabetes Mellitus

Mona Landin-Olssona Department of Medicine, Diabetes-and Endocrinology Clinic, University Hospital, S-221 85, Lund, SwedenCorrespondence[email protected]
,
Hans J. Arnqvistb Department of Endocrinology, University Hospital, Linköping, Sweden
,
Göran Blohméc Diabetes Center, Sahlgrenska University Hospital, Göteborg, Sweden
,
Bengt Littorind Primary Care Health Center, Landskrona, Sweden
,
Folke Lithnere Department of Medicine, University Hospital, Umeå, Sweden
,
Lennarth Nyströmf Department of Epidemiology and Public Health, Umeå University, Sweden
,
Bengt Scherstéang Primary Care Health Center, Dalby, Sweden
,
Göran Sundkvisth Department of Endocrinology, Malmö University Hospital, Sweden
,
Lars Wibelli Department of Medicine, Academic Hospital, Uppsala, Sweden
,
Jan Östmanj Center of Metabolism and Endocrinology, Huddinge Hospital, Sweden
&
Åke Lernmarkk RH Williams Laboratory, University of Washington, Seattle, USA
 show all
Pages 57-63 | Received 20 Jan 1998, Published online: 07 Jul 2009

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

C. Andersson, K. Larsson, F. Vaziri-Sani, K. Lynch, A. Carlsson, E. Cedervall, B. Jönsson, J. Neiderud, M. Månsson, A. Nilsson, Å. Lernmark, H. Elding Larsson & S.-A. Ivarsson. (2011) The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity 44:5, pages 394-405.
Read now
G. Erten, A.O. Gurol, G. Deniz, I. Satman & M.T. Yilmaz. (2007) Organ Specific Autoantibodies in Preclinical and Early Clinical Type 1 Diabetes in Turkey. Upsala Journal of Medical Sciences 112:2, pages 231-243.
Read now
J. Bolinder, P. Fernlund, H. Borg, H. J. Arnqvist, E. Björk, G. Blohmé, J. W. Eriksson, L. Nyström, J. Östman & G. Sundkvist. (2005) Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non‐autoimmune (type 2) diabetes. Scandinavian Journal of Clinical and Laboratory Investigation 65:7, pages 585-594.
Read now

Articles from other publishers (25)

Vijay Sheker Reddy Danda, Sandeep Reddy Devireddy, Srinivas Rao Paidipally, Piyush Lodha & Vivek Kyatham. (2023) Targeted next-generation sequencing for maturity onset diabetes of the young (MODY) in a South Indian cohort of type 1 diabetes mellitus patients with preserved C-peptide. International Journal of Diabetes in Developing Countries 44:2, pages 387-392.
Crossref
Sian Louise Grace, Jack Bowden, Helen C Walkey, Akaal Kaur, Shivani Misra, Beverley M Shields, Trevelyan J McKinley, Nick S Oliver, Timothy J McDonald, Desmond G Johnston, Angus G Jones & Kashyap A Patel. (2022) Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics. The Journal of Clinical Endocrinology & Metabolism 107:12, pages e4341-e4349.
Crossref
Lina Merjaneh, Lawrence M. Dolan, Cynthia K. Suerken, Ralph D'AgostinoJr.Jr., Giuseppina Imperatore, Sharon Saydah, Alissa Roberts, Santica Marcovina, Elizabeth J. Mayer‐Davis, Dana Dabelea, Jean M. Lawrence & Catherine Pihoker. (2022) A longitudinal assessment of diabetes autoantibodies in the SEARCH for diabetes in youth study . Pediatric Diabetes 23:7, pages 1027-1037.
Crossref
Seth A. SharpStephen S. Rich, Andrew R. WoodSamuel E. JonesRobin N. BeaumontJames W. HarrisonDarius A. Schneider, Jonathan M. Locke, Jess TyrrellMichael N. WeedonWilliam A. Hagopian & Richard A. Oram. (2019) Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis. Diabetes Care 42:2, pages 200-207.
Crossref
Elin P. Sørgjerd, Bjørn O. Åsvold, Per M. Thorsby & Valdemar Grill. (2018) Individuals Fulfilling Criteria for Type 2 Diabetes Rather Than LADA Display Transient Signs of Autoimmunity Preceding Diagnosis With Possible Clinical Implications: The HUNT Study. Diabetes Care 41:12, pages e161-e163.
Crossref
Hanna Skärstrand, Fariba Vaziri-Sani, Ahmed J Delli, Carina Törn, Helena Elding Larsson, Sten Ivarsson, Daniel Agardh & Åke Lernmark. (2015) Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients. Pediatric Diabetes 16:8, pages 621-628.
Crossref
N. Kanatsuna, A. Delli, C. Andersson, A.‐L. Nilsson, F. Vaziri‐Sani, K. Larsson, A. Carlsson, E. Cedervall, B. Jönsson, J. Neiderud, H. Elding Larsson, S.‐A. Ivarsson, C. Törn, M. Fex & Å. Lernmark. (2015) Doubly Reactive INS ‐ IGF 2 Autoantibodies in Children with Newly Diagnosed Autoimmune (type 1) Diabetes . Scandinavian Journal of Immunology 82:4, pages 361-369.
Crossref
Anna-Lena NilssonFariba Vaziri-SaniCecilia AnderssonKarin LarssonAnneli CarlssonElisabeth CedervallBjörn JönssonJan NeiderudHelena Elding LarssonSten-Anders IvarssonÅke Lernmark. (2013) Relationship Between Ljungan Virus Antibodies, HLA-DQ8, and Insulin Autoantibodies in Newly Diagnosed Type 1 Diabetes Children. Viral Immunology 26:3, pages 207-215.
Crossref
Takahiro Suzuki, Kenji Takahashi, Satoshi Miyamoto, Hiroyuki Ueno, Sato Takekawa, Atsushi Yoshida & Motohiro Fujita. (2007) "Type 1 on Type 2" Diabetes Mellitus: Autoimmune Type 1 Diabetes Superimposed on Established Type 2 Diabetes. Internal Medicine 46:24, pages 1957-1962.
Crossref
B. Berger, H. Borg, P. Fernlund, G. Stenström & G. Sundkvist. (2006) Islet antibodies associated with pancreatic B‐cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35–64 years old: degree of impairment less severe than in those aged 0–34 years old. Diabetic Medicine 23:11, pages 1180-1185.
Crossref
E. Bakhtadze, H. Borg, G. Stenström, P. Fernlund, H. J. Arnqvist, A. Ekbom-Schnell, J. Bolinder, J. W. Eriksson, S. Gudbjörnsdottir, L. Nyström, L. C. Groop & G. Sundkvist. (2006) HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden. Diabetologia 49:8, pages 1785-1794.
Crossref
K. Decochez, I. Truyen, B. Van der Auwera, I. Weets, E. Vandemeulebroucke, I. H. De Leeuw, B. Keymeulen, C. Mathieu, R. Rottiers, D. G. Pipeleers & F. K. Gorus. (2005) Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes. Diabetologia 48:4, pages 687-694.
Crossref
Shoichiro Tanaka, Toyoshi Endo, Kaoru Aida, Hiroki Shimura, Norihiko Yokomori, Masahiro Kaneshige, Fumihiko Furuya, Shin Amemiya, Mie Mochizuki, Koji Nakanishi & Tetsuro Kobayashi. (2004) Distinct Diagnostic Criteria of Fulminant Type 1 Diabetes Based on Serum C-Peptide Response and HbA1c Levels at Onset. Diabetes Care 27:8, pages 1936-1941.
Crossref
Toshikatsu Shigihara, Akira Shimada, Yoshihumi Saisho, Toshihide Kawai, Hiroshi Maruyama & Takao Saruta. (2004) Seroconversion of GAD Antibody in “Unclassified” Diabetes With Long Duration of Disease. Diabetes Care 27:7, pages 1836-1837.
Crossref
Dong Luo, Chad N Rogers, Jordan T Steed, Lisa K Gilliam, Christiane S Hampe & Åke Lernmark. (2004) Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin–GAD65 fusion protein. Journal of Biotechnology 111:1, pages 97-104.
Crossref
Harold Starkman & Shilpi Das. (2004) Cystic fibrosis presenting as new onset diabetes mellitus in adolescent twins. Pediatric Diabetes 5:2, pages 99-101.
Crossref
M. S. Ronkainen, K. Savola & M. Knip. (2004) Antibodies to GAD65 Epitopes at Diagnosis and Over the First 10 years of Clinical Type 1 Diabetes Mellitus. Scandinavian Journal of Immunology 59:3, pages 334-340.
Crossref
A. Schölin, L. Björklund, H. Borg, H. Arnqvist, E. Björk, G. Blohmé, J. Bolinder, J. W. Eriksson, S. Gudbjörnsdottir, L. Nyström, J. Östman, A. F. Karlsson & G. Sundkvist. (2004) Islet antibodies and remaining β‐cell function 8 years after diagnosis of diabetes in young adults: a prospective follow‐up of the nationwide Diabetes Incidence Study in Sweden. Journal of Internal Medicine 255:3, pages 384-391.
Crossref
Akira Shimada, Yoichi Oikawa, Toshikatsu Shigihara, Tomoko Senda & Keiichi Kodama. (2002) A Case of Fulminant Type 1 Diabetes With Strong Evidence of Autoimmunity. Diabetes Care 25:8, pages 1482-1483.
Crossref
Henrik Borg, Anders Gottsäter, Per Fernlund & Göran Sundkvist. (2002) A 12-Year Prospective Study of the Relationship Between Islet Antibodies and β-Cell Function At and After the Diagnosis in Patients With Adult-Onset Diabetes. Diabetes 51:6, pages 1754-1762.
Crossref
Jinko Graham, William A. Hagopian, Ingrid Kockum, Lou Sheng Li, Carani B. Sanjeevi, Robert M. Lowe, Jonathan B. Schaefer, Marjan Zarghami, Heather L. Day, Mona Landin-Olsson, Jerry P. Palmer, Marta Janer-Villanueva, Leroy Hood, Göran Sundkvist, Åke Lernmark, Norman Breslow, Gisela Dahlquist & Göran Blohmé. (2002) Genetic Effects on Age-Dependent Onset and Islet Cell Autoantibody Markers in Type 1 Diabetes. Diabetes 51:5, pages 1346-1355.
Crossref
O. Rolandsson, E. Hägg, M. Nilsson, G. Hallmans, L. Mincheva‐Nilsson & Å. Lernmark. (2001) Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population. Journal of Internal Medicine 249:4, pages 279-288.
Crossref
Y.-S. Lee, W.-Y. Ng, A.-C. Thai, K.-F. Lui & K.-Y. Loke. (2001) Prevalence of ICA and GAD Antibodies at Initial Presentation of Type 1 Diabetes Mellitus in Singapore Children. Journal of Pediatric Endocrinology and Metabolism 14:6.
Crossref
M Hoenig, C Reusch & M.E Peterson. (2000) Beta cell and insulin antibodies in treated and untreated diabetic cats. Veterinary Immunology and Immunopathology 77:1-2, pages 93-102.
Crossref
J. Östman, M. Landin‐Olsson, C. Törn, J. Palmer, Å. Lernmark, H. Arnqvist, E. Björk, J. Bolinder, G. Blohmé, J. Eriksson, B. Littorin, L. Nyström, B. Scherstén, G. Sundkvist & L. Wibell. (2002) Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus – a nationwide study. Diabetic Medicine 17:4, pages 269-274.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.